Special Issue in Honor of Dr. Marie-Hélène Metz-Boutigue 75th Birthday: “Recent Advances in Multifunctional Antimicrobial Peptides as Preclinical Therapeutic Studies and Clinical Future Applications”

doi:10.3390/books978-3-0365-9306-7

Download Url(s)

https://mdpi.com/books/pdfview/book/8321

Contributor(s)

Francesco, Scavello (editor)

Mohamed, Amiche (editor)

Ghia, Jean-Eric (editor)

Language

English

Show full item record

Abstract

Pharmaceutics is very pleased to be hosting a Special Issue in honor of Dr. Marie-Hélène Metz-Boutigue, acknowledging her influential scientific contributions to research on Antimicrobial Peptides (AMPs). This Special Issue aimed to gather and highlight significant advancements for AMPs as an alternative to antibiotics for increasing resistant strains and recent discoveries for future therapeutic approaches. Since the AMPs are multifunctional peptides with antitumor and immunomodulating effects, original research articles and reviews in these fields were particularly welcomed. Manuscripts regarding antimicrobial biomaterials including AMPs were also of interest.

URI

https://directory.doabooks.org/handle/20.500.12854/128851

Keywords

Escherichia coli; antimicrobial activity; structure-activity relationship; helical conformation; ultraviolet irradiation; UV; UVC; UVB; UVA; antimicrobial peptides; chemokines; cytokines; endodontic; inflammation; pain; tissue healing; multifunctional antimicrobial peptides; chromogranin A-derived peptides; immunomodulators; dermaseptins; anticancer activities; albumin; biomaterials; Catestatin; Chromogranin A; Chromofungin; critically ill; outcome; prognosis; superbugs; Vasostatin-I; cystic fibrosis; lung infection; biodegradable nanocarrier; therapeutic index; transepithelial resistance; lung gene expression; mouse bronchoalveolar lavage; chromogranin A; vasostatin-1; catestatin; angiogenesis; tumor diagnosis; neuropilin-1 integrin avβ6; integrin avβ8; immunogenicity; immunomodulation; biotherapeutics; in vitro T cell assay; assay validation; nisin–biogel; periodontal disease; dogs; clinical trial; anti-microbial peptides; antibiotic resistance; Gram-positive Gram-negative; fungi; antimicrobial peptide (AMP); multi-drug resistance (MDR); extracellular polymeric substances (EPSs); lipopolysaccharides (LPS); lipoteichoic acid (LTA); Klebsiella pneumoniae; colistin; antimicrobial resistance; mutation timing; evolution; biofilm; anti-inflammatory; PEGylation; glycosylation; gut microbiome; antimicrobial peptide; cell permeable peptide; n/a